Interviews
Exclusive conversations with CEOs and founders defining the cannabis economy.
Interviews · page 3
- Industry Trends
Is the German Cannabis Boom Slowing Down, or Simply Normalising?
Germany’s cannabis imports, according to the latest figures from BfArM, nearly tripled in size in 2025, cementing it beyond any doubt as the engine behind Europe’s medical cannabis boom.
- Industry Trends
Access, Saturation, Consolidation: Why Denmark Foreshadows the Future of Europe’s Medical Cannabis Markets
As Europe’s medical cannabis markets continue to mature, an increasingly familiar pattern is beginning to emerge.
- Clinical Research
Can the Company That Built Australia’s Pastilles Market Do It Again in the UK?
Australia’s booming medical cannabis market, now the largest outside of North America, has seen a dramatic shift in consumer preference over the last two years.
- Cultivation
Future-Ready: Why Pure Is Building the Cannabis Company Traditional Industry Will Want to Buy Into
Last year, as other European cannabis markets looked to be retreating from their ambitious progress in 2024, Switzerland accelerated its plans for cannabis reform.
- International Regulation
Germany’s Cannabis Future: Political Posturing vs. Market Reality
Last month (January 15, 2026) Germany’s Bundesrag held a debate on the hotly contested amendments aimed at significantly restricting medical cannabis prescriptions, and potentially transforming the industry.
- International Regulation
Is Europe Moving Away From Cannabis Flower?
Spain’s medicines agency has published the first official guidance for medical cannabis preparations, confirming that its incoming market will exclude raw cannabis flower in favour of ‘standardised’ oral solutions prepared exclusively in hospital pharmacies.
- Interviews
Legal Medicine Shouldn’t Make You Feel Like a Criminal at the Airport
The UK’s Border Force and airport security services have been on high alert for cannabis coming into and out of the country for some time, following a significant spike in seizures.
- Interviews
Why Curaleaf Laboratories Believes the UK Medical Cannabis Market Is Still Just Getting Started
As the UK’s medical cannabis patient population pushes past an estimated 60,000, questions about market maturity, patient access, and regulatory reform are more pressing than ever.
